American multinational pharmaceutical Pfizer will price its coronavirus (COVID-19) drug Paxlovid at $1,390 per course. The price of the five-day course of the COVID-19 antiviral drug will be set when the company starts to make it available to the commercial market later this year.

Pfizer to price Covid treatment Paxlovid at $1,390 per course

To combat a surge in Covid cases, China has given nod for the sale of Pfizer’s COVID-19 pill, Paxlovid, in the mainland. It comes after Beijing decided to move away from its stringent ‘zero-Covid’ policy in the wake of protests.

China allows sale of Pfizer oral drug as demand surges in wake of rising Covid cases

In a study published online on Tuesday (August 2), it is stated despite being treated with the antiviral Paxlovid, around a third of people with coronavirus (COVID-19) will experience a rebound of their symptoms.

COVID-19 can rebound even in those who haven't taken Paxlovid: Study

The "Paxlovid rebound" phenomenon has taken centre-stage after US President Joe Biden experienced a "rebound" case of COVID-19 last weekend after taking the drug.

‘Paxlovid rebound’: Why is this Covid drug given to Biden controversial? Check details

The World Health Organization (WHO) on Friday "strongly recommended" Pfizer’s COVID-19 antiviral pill Paxlovid for patients who have milder forms of the disease but are still at a high risk of hospitalisation, reports AFP.

Pfizer's anti-Covid pill gets WHO approval. Here's what you should know about Paxlovid

Israel on Thursday received first shipment of Pfizer's anti-Covid pill. Prime Minister Nafatali Bennett hailed it as critical to combat the Omicron threat. "Thanks to our rapid action, the drugs have arrived in Israel quickly and will assist us in getting past the peak of the coming Omicron wave," Bennett said.

First shipment of Pfizer's anti-Covid drug arrives in Israel

The United States has authorised Pfizer's anti-covid pill for people aged 12 or above who are at high risk, it's called Paxlovid; the pill comprises of two types of tablets. WION's correspondent Susan Tehrani brings in more information.

Omicron cases rise in the United States, authorities approve anti-covid pill Paxlovid

paxlovid

Paxlovid, News on Paxlovid, stories on Paxlovid, articles on Paxlovid, Paxlovid stories at Wion, Paxlovid news, Paxlovid latest news